欧塞塔米维尔治疗成年人流感:随机对照试验的元分析
Joanna Dobson1, Richard J Whitley2, Stuart Pocock1
1Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Lancet (London, England)
|February 3, 2015
概括
奥塞尔塔米维尔 (塔米弗鲁) 显著缩短了成年人流感症状的持续时间,并减少了诸如下呼吸道感染等并发症. 然而,它增加了恶心和吐的风险,没有观察到对严重不良事件的影响.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 欧塞塔米维尔在成年人流感治疗中的有效性仍然是正在进行的研究的主题.
- 广泛使用需要对其益处和风险有充分的了解.
研究的目的:
- 对成年人季节性流感进行oseltamivir临床试验的个人患者数据元分析.
- 与安慰剂相比,评估奥塞塔米维尔对缓解症状,并发症和安全性的影响.
主要方法:
- 系统审查和对已发表和未发表的随机,安慰剂控制,双盲试验的meta-analysis.
- 包括来自涉及自然发生的类似流感疾病的成年人试验的数据.
- 使用加速失效时间和风险比率方法分析感染的意图,治疗的意图和安全人群.
主要成果:
- 奥赛塔米维尔显著减少了21%的症状缓解时间 (平均差异为-25.2小时).
- 需要抗生素的下呼吸道并发症减少 (风险比0.56),以及住院 (风险比0.37).
- 在使用oseltamivir时观察到恶心 (9.9%vs6.2%) 和吐 (8.0%vs3.3%) 的发生率增加.
结论:
- 奥塞塔米维尔加速了成年流感患者的临床症状缓解.
- 该药物减少了下呼吸道并发症和住院住院的风险.
- 奥赛塔米维尔的使用与恶心和吐的增加有关.
相关概念视频
Influenza
57
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
57
Inhibitors of Viral Protein Synthesis
37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37
Drugs Used in Upper Respiratory Disorders: Overview
1.0K
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K


